{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:56Z","timestamp":1793327456666,"version":"4.5.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2025JBZX018"],"award-info":[{"award-number":["2025JBZX018"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2025JBZX0191"],"award-info":[{"award-number":["2025JBZX0191"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2225021"],"award-info":[{"award-number":["T2225021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32422042"],"award-info":[{"award-number":["32422042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232101"],"award-info":[{"award-number":["7232101"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124675","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:31:20Z","timestamp":1790836280000},"page":"124675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Reprogramming the therapeutic fate of living biotherapeutic products for intestinal diseases via biomaterials"],"prefix":"10.1016","volume":"338","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-7620","authenticated-orcid":false,"given":"Xiyu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-3187","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-9630","authenticated-orcid":false,"given":"Diwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2023.05.050","article-title":"Global burden of digestive diseases: a systematic analysis of the global burden of diseases study, 1990 to 2019","volume":"165","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cgh.2024.06.049","article-title":"The cost of inflammatory bowel disease care: how to make it sustainable","volume":"23","author":"Burisch","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"10114","key":"10.1016\/j.biomaterials.2026.124675_bib3","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8067","key":"10.1016\/j.biomaterials.2026.124675_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124675_bib6","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.1021\/acsnano.3c11089","article-title":"Orally administrated inflamed colon-targeted nanotherapeutics for inflammatory bowel disease treatment by oxidative stress level modulation in colitis","volume":"17","author":"Min","year":"2023","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124675_bib7","doi-asserted-by":"crossref","first-page":"19993","DOI":"10.1021\/acsnano.3c05143","article-title":"Near-Infrared-II-driven pollen micromotors for inflammatory bowel disease treatment","volume":"17","author":"Cai","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bjc.1987.25","article-title":"Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents","volume":"55","author":"Ijiri","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tgie.2016.07.006","article-title":"Diagnosing inflammatory bowel disease and differentiating it from potential mimics","volume":"18","author":"Clark-Snustad","year":"2016","journal-title":"Tech. Gastrointest. Endosc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib11","first-page":"40","article-title":"Current therapy in inflammatory bowel disease: why and how we need to change?","volume":"6","author":"Falloon","year":"2021","journal-title":"EMJ Innov"},{"issue":"30","key":"10.1016\/j.biomaterials.2026.124675_bib12","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer","volume":"28","author":"Quaglio","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0966-842X(96)10057-3","article-title":"The indigenous gastrointestinal microflora","volume":"4","author":"Berg","year":"1996","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/imt2.241","article-title":"Interaction between intestinal mycobiota and microbiota shapes lung inflammation","volume":"3","author":"Wang","year":"2024","journal-title":"iMeta"},{"issue":"51","key":"10.1016\/j.biomaterials.2026.124675_bib15","doi-asserted-by":"crossref","first-page":"11951","DOI":"10.1073\/pnas.1809349115","article-title":"Microbiome interactions shape host fitness","volume":"115","author":"Gould","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nchembio.741","article-title":"Bacteria and host interactions in the gut epithelial barrier","volume":"8","author":"Ashida","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/imt2.202","article-title":"The feasibility of using pathobiome strains as live biotherapeutic products for human use","volume":"3","author":"Jin","year":"2024","journal-title":"iMeta"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gutjnl-2024-334501","article-title":"Development of live biotherapeutic products: a position statement of Asia-Pacific microbiota consortium","volume":"74","author":"Tseng","year":"2025","journal-title":"Gut"},{"issue":"7826","key":"10.1016\/j.biomaterials.2026.124675_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2729-3","article-title":"Host-microbiota maladaptation in colorectal cancer","volume":"585","author":"Janney","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib20","first-page":"2438","article-title":"Protection of anaerobic microbes from processing stressors using metal-phenolic networks","volume":"144","author":"Fan","year":"2022","journal-title":"J. Appl. Comput. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrc.2017.13","article-title":"Microbiota: a key orchestrator of cancer therapy","volume":"17","author":"Roy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.chom.2018.07.019","article-title":"Temporal regulation of the bacterial metabolite deoxycholate during colonic repair is critical for crypt regeneration","volume":"24","author":"Jain","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2489067","article-title":"Precision microbiota therapy for IBD: premise and promise","volume":"17","author":"Nagayama","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biomaterials.2026.124675_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101291","article-title":"Biomaterials coating for on-demand bacteria delivery: selective release, adhesion, and detachment","volume":"41","author":"Liu","year":"2021","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124675_bib27","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"NEJM"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-020-06244-z","article-title":"Efficacy of single-strain probiotics versus multi-strain mixtures: systematic review of strain and disease specificity","volume":"66","author":"McFarland","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124675_bib29","first-page":"3680","article-title":"Oxygen metabolism and barrier regulation in the intestinal mucosa","volume":"126","author":"Glover","year":"2016","journal-title":"J. Clin. Immunoassay"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib30","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41564-024-01856-x","article-title":"Gut physiology and environment explain variations in human gut microbiome composition and metabolism","volume":"9","author":"Proch\u00e1zkov\u00e1","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124675_bib31","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ismej.2013.80","article-title":"Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis","volume":"7","author":"Rigottier-Gois","year":"2013","journal-title":"ISME J."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib32","first-page":"231","article-title":"Recent trends and applications of encapsulating materials for probiotic stability","volume":"53","author":"Riaz","year":"2013","journal-title":"Crit. Rev."},{"issue":"29","key":"10.1016\/j.biomaterials.2026.124675_bib33","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124675_bib34","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.drudis.2022.03.007","article-title":"Bacterial cancer therapy: a turning point for new paradigms","volume":"27","author":"Mayakrishnan","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.609722","article-title":"Probiotic gastrointestinal transit and colonization after oral administration: a long journey","volume":"11","author":"Han","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123163","article-title":"Inflammation-targeted delivery of probiotics for alleviation of colitis and associated cognitive disorders through improved vitality and colonization","volume":"318","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib39","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1038\/s41467-024-48128-0","article-title":"Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis","volume":"15","author":"Heavey","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s44385-024-00006-6","article-title":"Bacterial hitchhiking with drug-loaded nanoparticles as a drug delivery strategy for cancer immunotherapy","volume":"2","author":"Paun","year":"2025","journal-title":"NPJ Biomed Innov"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib41","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/s41467-019-11390-8","article-title":"Camouflaging bacteria by wrapping with cell membranes","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib42","first-page":"307","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China, Lancet gastroenterol","volume":"1","author":"Kaplan","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2468-1253(19)30358-9","article-title":"Global burden of inflammatory bowel disease","volume":"5","author":"Jairath","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124675_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124675_bib47","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/apt.17202","article-title":"Systematic review: the role of psychological stress in inflammatory bowel disease","volume":"56","author":"Black","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib48","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10014","key":"10.1016\/j.biomaterials.2026.124675_bib50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib51","first-page":"644","article-title":"Differential diagnosis of inflammatory bowel disease: imitations and complications","volume":"3","author":"Gecse","year":"2018","journal-title":"Lancet Gastroenterol"},{"issue":"6289","key":"10.1016\/j.biomaterials.2026.124675_bib52","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.aad9948","article-title":"Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease","volume":"352","author":"Chu","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib53","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/s41467-019-13336-6","article-title":"Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut","volume":"10","author":"Praveschotinunt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124675_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.136095","article-title":"Dual targeting procyanidin nanoparticles with glutathione response for colitis treatment","volume":"441","author":"Tie","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib55","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124675_bib56","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"NEJM"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41588-021-00968-y","article-title":"Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124675_bib58","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1039\/D3CS00369H","article-title":"Surface-modified bacteria: synthesis, functionalization and biomedical applications","volume":"52","author":"Lin","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124675_bib59","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1053\/j.gastro.2019.03.017","article-title":"Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases","volume":"156","author":"Cohen","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib60","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41467-021-23460-x","article-title":"Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis","volume":"12","author":"van der Lelie","year":"2021","journal-title":"Nat. Commun."},{"issue":"7152","key":"10.1016\/j.biomaterials.2026.124675_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20181198","article-title":"Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10","volume":"216","author":"Xiao","year":"2019","journal-title":"Exp. Med"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124675_bib63","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ibd\/izy385","article-title":"Anxiety but not depression predicts poor outcomes in inflammatory bowel disease","volume":"25","author":"Narula","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib64","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","article-title":"Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease","volume":"154","author":"Gracie","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib65","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib66","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/j.gastro.2021.08.060","article-title":"How should pain, fatigue, and emotional wellness be incorporated into treatment goals for optimal management of inflammatory bowel disease?","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib67","first-page":"53","article-title":"Current management of inflammatory bowel disease and colorectal cancer","volume":"4","author":"Mattar","year":"2011","journal-title":"GCR"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib69","first-page":"913","article-title":"The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"4","author":"Collaborators","year":"2019","journal-title":"Lancet Gastroenterol"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib70","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/medicina59091646","article-title":"Colorectal cancer: from risk factors to oncogenesis","volume":"59","author":"Ionescu","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Jess","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib72","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"10218","key":"10.1016\/j.biomaterials.2026.124675_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib76","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib77","first-page":"99","article-title":"Revisi\u00f3n y actualizaci\u00f3n general en c\u00e1ncer colorrectal","volume":"8","author":"Arcos","year":"2009","journal-title":"An. radiol. M\u00e9x"},{"key":"10.1016\/j.biomaterials.2026.124675_bib78","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-mediated drug delivery systems for the treatment of IBD: current perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib79","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124675_bib80","first-page":"768","article-title":"Treatment strategies in inflammatory bowel diseases","volume":"120","author":"Stallmach","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib81","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3904\/kjim.2022.132","article-title":"Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-\u03b1","volume":"37","author":"Park","year":"2022","journal-title":"Korean J. Intern. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/mejdd.2020.158","article-title":"Efficacy of Anti-TNF therapy for the treatment of patients with Moderate-to-Severe inflammatory bowel disease; a first Iranian report","volume":"12","author":"Mohagheghi Darehranj","year":"2020","journal-title":"Middle East J. Dig. Dis."},{"key":"10.1016\/j.biomaterials.2026.124675_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1089099","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise","year":"2023","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib84","first-page":"1273","article-title":"Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products","volume":"9","author":"Yeshi","year":"2020","journal-title":"Clin. Med."},{"issue":"300","key":"10.1016\/j.biomaterials.2026.124675_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10219","article-title":"An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae\/butyrate\/retinoic acid axis","volume":"6","author":"Wang","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"49","key":"10.1016\/j.biomaterials.2026.124675_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309370","article-title":"Precisely inhibiting excessive intestinal epithelial cell apoptosis to efficiently treat inflammatory bowel disease with oral pifithrin-\u03b1 embedded nanomedicine (OPEN)","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124675_bib88","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.ejca.2015.06.116","article-title":"Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)","volume":"51","author":"Heinemann","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124675_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109142","article-title":"Natural products for treating colorectal cancer: a mechanistic review","volume":"117","author":"Huang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib90","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/curroncol32110639","article-title":"Efficacy of Anti-VEGF and Anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer in a turkish oncology group (TOG) cohort study","volume":"32","author":"Delikta\u015f","year":"2025","journal-title":"Curr. Oncologist"},{"key":"10.1016\/j.biomaterials.2026.124675_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.104028","article-title":"Safety and efficacy of nivolumab plus ipilimumab in microsatellite instability\u2013high\/mismatch repair\u2013deficient colorectal cancer: a systematic review","volume":"51","author":"Kokori","year":"2026","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1045575","article-title":"Targeting pathophysiological changes using biomaterials-based drug delivery systems: a key to managing inflammatory bowel disease","volume":"13","author":"Mohajeri","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib93","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13346-018-0512-x","article-title":"Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects","volume":"9","author":"Sohail","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib94","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/md23120467","article-title":"Chitosan-based drug delivery systems for targeted chemotherapy in colorectal cancer: a scoping review","volume":"23","author":"Piotrowska","year":"2025","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib95","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/thno.85917","article-title":"Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors","volume":"14","author":"Zheng","year":"2024","journal-title":"Theranostics"},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124675_bib96","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1021\/acs.biochem.2c00251","article-title":"Engineered cancer targeting microbes and encapsulation devices for human gut microbiome applications","volume":"61","author":"Hamidi Nia","year":"2022","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib97","first-page":"1759","article-title":"Probiotics: the scientific evidence in the context of inflammatory bowel disease","volume":"57","author":"Celiberto","year":"2017","journal-title":"Crit. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib98","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1021\/acs.nanolett.7b05323","article-title":"Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-\u03b1 expression via oral administration","volume":"18","author":"Fan","year":"2018","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib99","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nnano.2016.137","article-title":"Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions","volume":"11","author":"Felfoul","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.tim.2018.08.005","article-title":"Bacteroides thetaiotaomicron","volume":"26","author":"Porter","year":"2018","journal-title":"Trends Microbiol."},{"issue":"38","key":"10.1016\/j.biomaterials.2026.124675_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102580","article-title":"Chemically and biologically engineered bacteria-based delivery systems for emerging diagnosis and advanced therapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"issue":"sup1","key":"10.1016\/j.biomaterials.2026.124675_bib102","first-page":"130","article-title":"Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria","volume":"59","author":"Fu","year":"2019","journal-title":"Crit. Rev."},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124675_bib103","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"P. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib104","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"Surg Sect","key":"10.1016\/j.biomaterials.2026.124675_bib105","first-page":"1","article-title":"The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus prodigiosus)","volume":"3","author":"Coley","year":"1910","journal-title":"Proc. Roy. Soc. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib106","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41467-018-03233-9","article-title":"Optically-controlled bacterial metabolite for cancer therapy","volume":"9","author":"Zheng","year":"2018","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124675_bib107","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"P. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124675_bib108","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1158\/1078-0432.CCR-24-3952","article-title":"Abstract CT107: phase Ib study of pembrolizumab in combination with intratumoral injection of Clostridium novyi-NT in patients with advanced solid tumors","volume":"31","author":"Nelson","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124675_bib109","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1016\/j.apsb.2022.05.006","article-title":"Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124675_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202405075","article-title":"Harnessing and mimicking bacterial features to combat cancer: from living entities to artificial mimicking systems","volume":"36","author":"Gao","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib111","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1021\/acsnano.1c00135","article-title":"Optotheranostic nanosystem with phone visual diagnosis and optogenetic microbial therapy for ulcerative colitis at-home care","volume":"15","author":"Cui","year":"2021","journal-title":"ACS Nano"},{"issue":"6622","key":"10.1016\/j.biomaterials.2026.124675_bib112","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib113","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1073\/pnas.1918859117","article-title":"Chromosome-free bacterial cells are safe and programmable platforms for synthetic biology","volume":"117","author":"Fan","year":"2020","journal-title":"P. Natl. Acad. Sci. USA"},{"issue":"32","key":"10.1016\/j.biomaterials.2026.124675_bib114","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221121120","article-title":"Engineered calprotectin-sensing probiotics for IBD surveillance in humans","volume":"120","author":"Xia","year":"2023","journal-title":"P. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.chom.2022.12.004","article-title":"Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice","volume":"31","author":"Zou","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124675_bib116","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.3879","article-title":"Engineered bacteria can function in the Mammalian gut long-term as live diagnostics of inflammation","volume":"35","author":"Riglar","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109690","article-title":"NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut","volume":"36","author":"Cui","year":"2021","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124675_bib118","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s41423-021-00760-2","article-title":"Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis","volume":"18","author":"Yan","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib119","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241253089","article-title":"Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone","volume":"17","author":"DuPont","year":"2024","journal-title":"Therapeut. Adv. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3904\/kjim.2021.458","article-title":"Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis","volume":"37","author":"Park","year":"2022","journal-title":"Korean J Intern. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib121","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"issue":"6349","key":"10.1016\/j.biomaterials.2026.124675_bib122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib123","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10637-025-01573-0","article-title":"Phase 1\/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor-relapsed tumors","volume":"43","author":"Wang","year":"2025","journal-title":"Invest. N. Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.biomaterials.2026.124675_bib124","article-title":"493 Akkermansia muciniphila reprograms immunosuppressive microenvironment via efferocytosis inhibition to sensitize anti-PD-1 therapy in MSS colorectal cancer: phase I trial","volume":"13","author":"Jiang","year":"2025","journal-title":"Immuno. Thermoelectrics"},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2026.124675_bib125","article-title":"P0059 mechanistic understanding of MB310: a consortium of gut commensal bacteria for the treatment of ulcerative colitis","volume":"19","author":"Schreiber","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biomaterials.2026.124675_bib126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.copbio.2017.08.008","article-title":"To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes","volume":"49","author":"Walter","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib127","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2018.01.003","article-title":"Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation","volume":"23","author":"Smillie","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biomaterials.2026.124675_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2021.107112","article-title":"Multi-layer PLGA-pullulan-PLGA electrospun nanofibers for probiotic delivery","volume":"123","author":"Ajalloueian","year":"2022","journal-title":"Food Hydrocoll."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41575-021-00539-w","article-title":"Foundations of gastrointestinal-based drug delivery and future developments","volume":"19","author":"Chu","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2022.06.061","article-title":"Novel nano-encapsulated probiotic agents: encapsulate materials, delivery, and encapsulation systems","volume":"349","author":"Xu","year":"2022","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib131","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/1541-4337.12532","article-title":"Progress in microencapsulation of probiotics: a review","volume":"19","author":"Yao","year":"2020","journal-title":"Compr. Rev. Food Sci. F."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib132","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/jam.13740","article-title":"Microencapsulation increases survival of the probiotic Lactobacillus plantarum IS-10506, but not Enterococcus faecium IS-27526 in a dynamic, computer-controlled in vitro model of the upper gastrointestinal tract","volume":"124","author":"Surono","year":"2018","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib133","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tifs.2019.12.019","article-title":"Construction of food-grade pH-sensitive nanoparticles for delivering functional food ingredients","volume":"96","author":"Xiong","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.07.012","article-title":"Micro and nanoscale technologies in oral drug delivery","volume":"157","author":"Ahadian","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124675_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110743","article-title":"The final fate of food: on the establishment of in vitro colon models","volume":"150","author":"Hernalsteens","year":"2021","journal-title":"Food Res. Int."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124675_bib136","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nri.2016.88","article-title":"Immunological aspects of intestinal mucus and mucins","volume":"16","author":"Johansson","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib137","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib138","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acs.bioconjchem.3c00549","article-title":"Passivating the background of living microbes with a Zwitterionic peptide for therapies","volume":"35","author":"Fang","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2026.124675_bib139","doi-asserted-by":"crossref","first-page":"49","DOI":"10.34133\/bdr.0049","article-title":"Dynamic gene expression mitigates mutational escape in lysis-driven bacteria cancer therapy","volume":"6","author":"Liguori","year":"2024","journal-title":"Biodes. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13059-026-03951-0","article-title":"Rational engineering of combinatorial bacterial therapies for cancer","volume":"27","author":"Steppe","year":"2026","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib141","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12934-026-02997-w","article-title":"From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics","volume":"25","author":"Di Pierro","year":"2026","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib142","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-024-55347-y","article-title":"Design principles for engineering bacteria to maximize chemical production from batch cultures","volume":"16","author":"Mannan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124675_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/frmbi.2025.1569348","article-title":"Chemistry, manufacturing, and controls for live microbial products: addressing classification challenges and enhancing process validation","volume":"4","author":"Slijkerman","year":"2025","journal-title":"Front. Microbiomes"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib144","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3168\/jds.2019-17685","article-title":"Influence of freezing temperature before freeze-drying on the viability of various Lactobacillus plantarum strains","volume":"103","author":"Wang","year":"2020","journal-title":"J. Dairy Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jam.13465","article-title":"Influence of freezing temperatures prior to freeze-drying on viability of yeasts and lactic acid bacteria isolated from wine","volume":"122","author":"Polo","year":"2017","journal-title":"Appl. Microbiol."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124675_bib146","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202521766","article-title":"Living hydrogels: harnessing microorganism\u2013material synergy for next\u2010generation therapeutics","volume":"13","author":"Mao","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124675_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417050","article-title":"Synergistic genetic and chemical engineering of probiotics for enhanced intestinal microbiota regulation and ulcerative colitis treatment","author":"Jiang","year":"2025","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib155","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1021\/nn5011304","article-title":"Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents","volume":"8","author":"Taherkhani","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124675_bib156","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.snb.2015.09.034","article-title":"Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella Typhimurium)","volume":"224","author":"Nguyen","year":"2016","journal-title":"Sens. Actuators, B"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124675_bib157","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.apsb.2025.05.040","article-title":"Improved prebiotic-based \"shield\" equipped probiotics for enhanced colon cancer therapy by polarizing M1 macrophages and regulating intestinal microbiota","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124675_bib158","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eng.2023.05.024","article-title":"A double-layer polysaccharide hydrogel (DPH) for the enhanced intestine-targeted oral delivery of probiotics","volume":"34","author":"Huang","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.biomaterials.2026.124675_bib159","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.actbio.2023.07.051","article-title":"Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression","volume":"169","author":"Wu","year":"2023","journal-title":"Acta Biomater."},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124675_bib160","doi-asserted-by":"crossref","first-page":"26858","DOI":"10.1021\/acsnano.4c08117","article-title":"Spatiotemporal delivery of dual nanobodies by engineered probiotics to reverse tumor immunosuppression via targeting tumor-derived exosomes","volume":"18","author":"Qin","year":"2024","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124675_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909806","article-title":"Self\u2010mineralized photothermal bacteria hybridizing with mitochondria\u2010targeted metal\u2013organic frameworks for augmenting photothermal tumor therapy","volume":"30","author":"Chen","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124675_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122584","article-title":"Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery","volume":"309","author":"Li","year":"2024","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124675_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417920","article-title":"TREM2 scFv-engineering Escherichia coli displaying modulation of macrophages to boost cancer radio-immunotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106669","article-title":"Spatiotemporally controllable distribution of combination therapeutics in solid tumors by dually modified bacteria","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124675_bib165","article-title":"Decorating bacteria with triple immune nanoactivators generates tumor-resident living immunotherapeutics","volume":"61","author":"Li","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124675_bib166","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/sciadv.abf0677","article-title":"Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches","volume":"7","author":"Lin","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124675_bib148","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124675_bib149","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124675_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100876","article-title":"Multi-functional liposome: a powerful theranostic nano-platform enhancing photodynamic therapy","volume":"8","author":"Cheng","year":"2021","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124675_bib152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib154","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132063","article-title":"Layer-by-layer coated probiotics with chitosan and liposomes exhibit enhanced therapeutic effects for DSS-induced colitis in mice","volume":"269","author":"Han","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124675_bib168","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/gels12070578","article-title":"Biomedical hydrogels based on natural polysaccharides: structural design","volume":"12","author":"Liu","year":"2026","journal-title":"Gels"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124675_bib169","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1021\/acs.chemrev.0c00345","article-title":"Hydrogels and hydrogel-derived materials for energy and water sustainability","volume":"120","author":"Guo","year":"2020","journal-title":"Chem. Rev."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124675_bib170","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1021\/acs.chemrev.1c00046","article-title":"Mechanics of 3D cell-hydrogel interactions: experiments, models, and mechanisms","volume":"121","author":"Vernerey","year":"2021","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124675_bib171","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202109833","article-title":"Programmable building of radially gradient nanofibrous patches enables deployment, bursting bearing capability, and stem cell recruitment","volume":"32","author":"Du","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124675_bib172","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1016\/j.biomaterials.2014.04.029","article-title":"Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI","volume":"35","author":"Cheng","year":"2014","journal-title":"Biomaterials"},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124675_bib173","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1002\/adfm.201401110","article-title":"In situ crosslinkable gelatin hydrogels for vasculogenic induction and delivery of mesenchymal stem cells","volume":"24","author":"Lee","year":"2014","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib174","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/md19030145","article-title":"Cosmetic, biomedical and pharmaceutical applications of fish gelatin\/hydrolysates","volume":"19","author":"Al-Nimry","year":"2021","journal-title":"Mar. Drugs"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib175","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.apsb.2020.01.009","article-title":"Delivery strategies for macromolecular drugs in cancer therapy","volume":"10","author":"Guo","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib176","doi-asserted-by":"crossref","first-page":"17870","DOI":"10.1021\/acsnano.1c06123","article-title":"A self-driven bioreactor based on bacterium-metal-organic framework biohybrids for boosting chemotherapy via cyclic lactate catabolism","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124675_bib177","doi-asserted-by":"crossref","first-page":"18078","DOI":"10.1002\/anie.202008858","article-title":"Construction of flexible-on-rigid hybrid-phase metal-organic frameworks for controllable multi-drug delivery","volume":"59","author":"Wang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"31","key":"10.1016\/j.biomaterials.2026.124675_bib178","doi-asserted-by":"crossref","first-page":"16763","DOI":"10.1002\/anie.202102574","article-title":"Antitumor agents based on metal-organic frameworks","volume":"60","author":"Gao","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib179","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chempr.2017.02.005","article-title":"Selective surface PEGylation of UiO-66 nanoparticles for enhanced stability, cell uptake, and pH-responsive drug delivery","volume":"2","author":"Ab\u00e1nades L\u00e1zaro","year":"2017","journal-title":"Chem"},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124675_bib180","doi-asserted-by":"crossref","first-page":"38989","DOI":"10.1021\/acsami.0c10900","article-title":"Evaluating UiO-66 metal-organic framework nanoparticles as acid-sensitive carriers for pulmonary drug delivery applications","volume":"12","author":"Jarai","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107560","article-title":"Biodegradable metal-organic-framework-gated organosilica for tumor-microenvironment-unlocked glutathione-depletion-enhanced synergistic therapy","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907152","article-title":"A metal-organic framework (MOF) Fenton nanoagent-enabled nanocatalytic cancer therapy in synergy with autophagy inhibition","volume":"32","author":"Yang","year":"2020","journal-title":"Adv. Mater."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124675_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100333","article-title":"Conferring Ti-based MOFs with defects for enhanced sonodynamic cancer therapy","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib184","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/1751-7915.14007","article-title":"Preservation by lyophilization of a human intestinal microbiota: influence of the cultivation pH on the drying outcome and re-establishment ability","volume":"15","author":"Haindl","year":"2022","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib185","article-title":"3D printed pH-responsive colonic capsules for the delivery of live aqueous bacterial suspensions","volume":"104","author":"Abdi","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib186","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/17425247.2017.1360864","article-title":"Enteric coatings for colonic drug delivery: state of the art","volume":"14","author":"Maroni","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124675_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202512642","article-title":"Orthogonal tri-modular coiled-coil assembly for programmable multi-cargo display on Escherichia coli nissle 1917","volume":"22","author":"Cho","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124675_bib188","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-026-01827-1","article-title":"From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine","volume":"19","author":"Qiao","year":"2026","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib189","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12195-024-00819-w","article-title":"A new bacterial chassis for enhanced surface display of recombinant proteins","volume":"17","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Bioeng."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib190","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1021\/acsnano.1c09818","article-title":"Intravenous delivery of living Listeria monocytogenes elicits gasdermin-dependent tumor pyroptosis and motivates anti-tumor immune response","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124675_bib191","article-title":"Surface modifications for improved delivery and function of therapeutic bacteria","volume":"16","author":"Vargason","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124675_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123339","article-title":"Orally-deliverable liposome-microgel complexes dynamically remodel intestinal environment to enhance probiotic ulcerative colitis therapy via TLR4 inhibition and tryptophan metabolic crosstalk","volume":"321","author":"Fu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124675_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114443","article-title":"Decorated bacteria and the application in drug delivery","volume":"188","author":"Wu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124675_bib194","article-title":"Analysis of the most frequent nonconformance aspects related to Good manufacturing practices (GMP) among small and medium enterprises (SMEs) in the food industry and their main factors","volume":"141","author":"Hasnan","year":"2022","journal-title":"Food Control"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0142-9612(90)90038-R","article-title":"Future directions in biomaterials","volume":"11","author":"Langer","year":"1990","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib196","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/microorganisms14020467","article-title":"Genetically modified microorganisms: risks and regulatory considerations for human and environmental health","volume":"14","author":"Lerner","year":"2026","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib197","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/s41598-017-02591-6","article-title":"Use of genetically modified bacteria for drug delivery in humans: revisiting the safety aspect","volume":"7","author":"Wegmann","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124675_bib198","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1073\/pnas.1113246109","article-title":"Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae","volume":"109","author":"Stecher","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib199","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10482-009-9401-0","article-title":"Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans","volume":"97","author":"Egerv\u00e4rn","year":"2010","journal-title":"Antonie Leeuwenhoek"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib200","article-title":"Synthetic biology-inspired biocontainment strategies of therapeutic genetically engineered bacteria","volume":"4","author":"Gan","year":"2026","journal-title":"Synth. Biol. Eng."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124675_bib201","article-title":"Multiscale hybrid surface topographies orchestrate immune regulation, antibacterial defense, and tissue regeneration","volume":"15","author":"Asadi Tokmedash","year":"2026","journal-title":"Adv. Healthcare Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124675_bib202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.addr.2019.06.008","article-title":"Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems","volume":"143","author":"Su","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124675_bib203","article-title":"Toxicity and biocompatibility of Metal\u2013organic frameworks: a comprehensive review of biomedical applications","volume":"123","author":"Azadvar","year":"2026","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib204","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/pharmaceutics18050548","article-title":"Safety, in vivo fate, and degradation of MOF nanomedicines: toward translational evaluation","volume":"18","author":"Jing","year":"2026","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124675_bib205","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/polym18131667","article-title":"Poly(methyl vinyl ether-alt-maleic anhydride) and its derivatives: from polymer synthesis to advanced biomedical applications","volume":"18","author":"Bad\u00eda-Hern\u00e1ndez","year":"2026","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124675_bib206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/biomedicines13020299","article-title":"Anti-drug antibody response to therapeutic antibodies and potential mitigation strategies","volume":"13","author":"Howard","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biomaterials.2026.124675_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214182","article-title":"A practical workflow for cytocompatibility assessment of living therapeutic materials","volume":"169","author":"Mekontso","year":"2025","journal-title":"Biomater. Adv"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124675_bib208","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/acsbiomaterials.5c00247","article-title":"Preclinical assessment of living therapeutic materials: State-of-Art and challenges","volume":"11","author":"Desai","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2026.124675_bib209","article-title":"A screening setup to streamline in vitro engineered living material cultures with the host","volume":"30","author":"Desai","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"6594","key":"10.1016\/j.biomaterials.2026.124675_bib210","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1126\/science.abm6038","article-title":"Noninvasive assessment of gut function using transcriptional recording sentinel cells","volume":"376","author":"Schmidt","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib211","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","article-title":"The expanding vistas of spatial transcriptomics","volume":"41","author":"Tian","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib212","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","article-title":"Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts","volume":"14","author":"Ning","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib213","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/pharmaceutics18060764","article-title":"Artificial intelligence in nanopharmaceutical development: from predictive design to clinical translation","volume":"18","author":"Gon\u00e7alves","year":"2026","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib214","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13036-025-00479-y","article-title":"Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits","volume":"19","author":"Woo","year":"2025","journal-title":"J. Biol. Eng."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124675_bib215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44320-025-00123-3","article-title":"A discovery platform for identification of host-induced bacterial biosensors from diverse sources","volume":"21","author":"Robinson","year":"2025","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.biomaterials.2026.124675_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2025.103375","article-title":"Programmable probiotics as next-generation living therapeutics: bridging synthetic biology and precision medicine","volume":"96","author":"Li","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124675_bib217","article-title":"Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing","volume":"15","author":"Barberio","year":"2024","journal-title":"Front. Microbiomes"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124675_bib218","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cmi.2026.01.021","article-title":"Microbiome research in practice: priorities for clinical translation and impact","volume":"32","author":"Theodosiou","year":"2026","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib219","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12934-020-01350-z","article-title":"Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice","volume":"19","author":"Bai","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.biomaterials.2026.124675_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122970","article-title":"Remolding probiotics for effective treatment of type 2 diabetes via oral administration","volume":"315","author":"Ji","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib221","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2309683","article-title":"Phocaiecola vulgatus alleviates diet-induced metabolic dysfunction\u2013associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA","volume":"16","author":"Jin","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124675_bib222","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124675_bib223","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/metabo12121247","article-title":"Modulatory effect of gut microbiota on the Gut-Brain, gut-bone axes, and the impact of cannabinoids","volume":"12","author":"Ibrahim","year":"2022","journal-title":"Metabolites"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600699X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600699X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:37:01Z","timestamp":1793324221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122600699X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":223,"alternative-id":["S014296122600699X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124675","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming the therapeutic fate of living biotherapeutic products for intestinal diseases via biomaterials","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124675"}}